Oslo-based Verdane closes Edda III past target at €1.1 billion doubling its predecessor fund

Published on February 26, 2024

Verdane, a European specialist growth investment firm, announced the successful final close of Verdane Edda III (“Edda III” or “the Fund”) at €1.1 billion, significantly past its target. In the past six months, Verdane has successfully closed two funds above target, together totalling €2.2 billion, including the €1.1 billion Freya XI fund which held its…

This content is for members only. Visit the site and log in/register to read.

The post Oslo-based Verdane closes Edda III past target at €1.1 billion doubling its predecessor fund appeared first on EU-Startups.

Continue reading on website
Other news

Paris-based Sorella secures €5 million to further strenght its hybrid healthcare offering for female health

February 26, 2024
Just 1 year after the opening of its first multidisciplinary health clinic, female health startup Sorella has closed a €5 million seed round to help improve female health in France and beyond. The funding round was led by blisce/, Vorwerk Ventures joined the round. blisce/, is a certified B Corp impact investment firm for which… This content is for members only. Visit the site and log in/register

Jumpstart Your Portfolio With These 3 Biotech Stocks

February 26, 2024
The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex...